Solara Active Pharma Sciences announced that Crisil ESG Ratings & Analytics has assigned an Environmental, Social and Governance (ESG) rating of “Crisil ESG 56” – under ‘Adequate' category (improved from “Crisil ESG 53” for the period ended 31 March 2024).